Rare Disease Innovation & Partnering Summit

18 May 2022 02:30 p.m. - 03:15 p.m.

Revere Hotel Boston Common
200 Stuart St
Boston, MA 02116

Morrison & Foerster is proud to sponsor Informa's 2022 Rare Disease Innovation & Partnering Summit on May 17-19. This hybrid event will take place in Boston.

Join Morrison & Foerster attorneys Erik Olson and Brigid Bondoc and Advanced Cell & Gene Therapy Principal Scott Burger on May 18th from 2:30-3:15pm EST as they participate in the panel, Uncover Risk Disclosures for Gene Therapies.

During this session, speakers will:

  • Outline the risks of gene therapy and how they have changed over the years as the science has improved
  • Discuss how the SEC thinks about risk disclosure, particularly in a situation where the risk isn’t just money
  • Discuss the FDA’s role in controlling risk and balancing against benefits and cooperation with SEC
  • Explore shareholder litigation
  • Participate in case studies

The conference will focus on solution-focused strategies surrounding patient access, reimbursement, commercialization, launch, partnering and more. Join experts across the rare disease community, in-person or virtually, to unite in areas of unmet medical need and create life-transforming therapies and breakthroughs.



Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.